Robert Nelsen - Director at Denali Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
DNLI on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Robert Nelsen since 7/7/2023

Holdings reported by Robert Nelsen for Denali Therapeutics Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 9,668,749 $178 M $18.42 Jun 2, 2021 Held by ARCH Venture Fund VIII, L.P.
Common Stock 12,432 $229 K $18.42 Jun 2, 2021 Direct
Stock Option (right to buy) 6,222 Jun 2, 2021 Direct Common Stock
Restricted Stock Units 0 Jun 1, 2021 Direct Common Stock

Transactions reported by Robert Nelsen for Denali Therapeutics Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership